首页 >
法规速递
-
Document: Questions and answers about the SEND proof-of-concept for industry: Scope, terms of participation and data submission process-2025/6/16
2025-06-17查看详情 > -
Document: PMS data matrix - Cross-platforms-2025/7/18
2025-07-21查看详情 > -
关于公开征求《针对泛肿瘤的抗肿瘤药物临床研发技术指导原则（征求意见稿）》意见的通知-2025/9/4
2025-09-05查看详情 > -
Document: Halocur : EPAR - All Authorised presentations-2025/10/7
2025-10-08查看详情 > -
图解海报 | 《医疗器械生产质量管理规范》系列解读（七）-2025/11/16
2025-11-17查看详情 > -
Document: Draft guideline on quality of radiopharmaceuticals - Revision 2-2025/12/10
2025-12-11查看详情 > -
Document: Reflection paper on investigation and assessment of cardiovascular safety of anticancer medicinal products-2026/1/23
2026-01-26查看详情 > -
关于公开征求《罕见疾病创新药物研发鼓励试点计划（“关爱计划-延伸”）》相关工作文件意见的通知-2026/2/28
2026-02-28查看详情 > -
Page: Submitting results of paediatric studies-2026/3/27
2026-03-30查看详情 > -
Document: Olazax : EPAR - Procedural steps taken and scientific information after authorisation (archive)-2026/5/11
2026-05-12查看详情 >
